PMID: 6169979Oct 1, 1981Paper

An expanded concept of "insurance" supplementation--broad-spectrum protection from cardiovascular disease

Medical Hypotheses
M F McCarty

Abstract

The preventive merits of "nutritional insurance" supplementation can be considerably broadened if meaningful doses of nutrients such as mitochondrial "metavitamins" (coenzyme Q, lipoic acid, carnitine), lipotropes, and key essential fatty acids, are included in insurance supplements. From the standpoint of cardiovascular protection, these nutrients, as well as magnesium, selenium, and GTF-chromium, appear to have particular value. Sophisticated insurance supplementation would likely have a favorable impact on many parameters which govern cardiovascular risk--serum lipid profiles, blood pressure, platelet stability, glucose tolerance, bioenergetics, action potential regulation--and as a life-long preventive health strategy might confer substantial benefit.

References

Jun 12, 1976·Lancet·M F Lopes-Virella, J A Colwell
Feb 10, 1979·Lancet·M JohnsonJ B Elder
Jan 1, 1975·The Journal of Clinical Investigation·M A D'Costa, A Angel
Jan 1, 1975·Biochemical Pharmacology·B B Fredholm, P Hedqvist
Feb 5, 1976·The New England Journal of Medicine·G G RhoadsA Kagan
Nov 1, 1977·Metabolism: Clinical and Experimental·J L Goldstein, M S Brown
Jun 1, 1978·European Journal of Clinical Investigation·E A Nikkila
Jun 1, 1978·Australian and New Zealand Journal of Medicine·V J McCann, R E Davis
Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J R PatschS Eisenberg
Nov 15, 1979·The New England Journal of Medicine·A P GoldbergE A Nikkila
Dec 3, 1977·British Medical Journal·P B KernoffG P McNicol
Jun 1, 1978·The American Journal of Cardiology·J D FoltsN Bittar
Jan 1, 1976·Japanese Heart Journal·T IshiyamaN Tsukamoto
Jan 1, 1975·Annual Review of Pharmacology·D V Frost, P M Lish
Dec 1, 1976·Journal of the American Geriatrics Society·I MachteyH Löbel
May 1, 1975·Nutrition Reviews·W Mertz
May 26, 1973·Lancet·G HornstraA J Vergroesen
Aug 1, 1973·British Journal of Urology·C Williams
Dec 1, 1974·Transactions of the New York Academy of Sciences·R J Kones
Oct 1, 1967·European Journal of Pharmacology·A BizziR Paoletti
Dec 1, 1970·Metabolism: Clinical and Experimental·W N KelleyJ E Seegmiller
Nov 17, 1971·Nature: New Biology·G Illiano, P Cuatrecasas

❮ Previous
Next ❯

Citations

Oct 7, 2003·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Palaniyappan ArivazhaganChinnakkanu Panneerselvam
Nov 1, 1991·Hypertension·E S Ford, R S Cooper
Jan 17, 2007·Molecular and Cellular Biochemistry·Ganapathy AmudhaPalaninathan Varalakshmi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

© 2021 Meta ULC. All rights reserved